Cresset Biomolecular Discovery Overview
- Year Founded
-
2002
- Status
-
Private
- Employees
-
99
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
5
- Investments
-
1
Cresset Biomolecular Discovery General Information
Description
Developer of computational molecular design and simulation software designed to accelerate drug discovery workflows by predicting molecular interactions and prioritising drug candidates. The company's software suite specializes in providing flare methods for protein-ligand systems, virtual screening, spark methods to discover direction, protein-ligand docking and molecular design, enabling clients to make design and synthesis decisions efficiently.
Contact Information
Website
www.cresset-group.comCorporate Office
- New Cambridge House
- Bassingbourn Road
- Litlington SG8 0SS
- England, United Kingdom
Corporate Office
- New Cambridge House
- Bassingbourn Road
- Litlington SG8 0SS
- England, United Kingdom
Cresset Biomolecular Discovery Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Cresset Biomolecular Discovery Comparisons
Industry
Financing
Details
Cresset Biomolecular Discovery Competitors (16)
One of Cresset Biomolecular Discovery’s 16 competitors is Chemical Computing Group, a Private Equity-Backed company based in Montreal, Canada.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Chemical Computing Group | Private Equity-Backed | Montreal, Canada | ||||
| Conifer Point Pharmaceuticals | Corporate Backed or Acquired | Doylestown, PA | ||||
| Chemify | Venture Capital-Backed | Glasgow, United Kingdom | ||||
| MathWorks (Business/Productivity Software) | Corporation | Natick, MA | ||||
| Yoneda Labs | Venture Capital-Backed | San Francisco, CA |
Cresset Biomolecular Discovery Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Cresset Biomolecular Discovery Patents
Cresset Biomolecular Discovery Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2014252807-A1 | The local treatment of inflammatory ophthalmic diseases | Inactive | 09-Apr-2013 | ||
| CA-2909111-A1 | The local treatment of inflammatory ophthalmic diseases | Inactive | 09-Apr-2013 | ||
| EP-2983788-A1 | The local treatment of inflammatory ophthalmic diseases | Inactive | 09-Apr-2013 | ||
| GB-201406390-D0 | The local treatment of inflammatory ophthalmic diseases | Active | 09-Apr-2013 | ||
| GB-2516137-A | The local treatment of inflammatory ophthalmic diseases | Active | 09-Apr-2013 | A61K31/4375 |
Cresset Biomolecular Discovery Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Cresset Biomolecular Discovery Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Cresset Biomolecular Discovery Investments (1)
Cresset Biomolecular Discovery’s most recent deal was a Buyout/LBO with Molab.ai. The deal was made on 08-Jul-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Molab.ai | 08-Jul-2025 | Buyout/LBO | Discovery Tools (Healthcare) |
Cresset Biomolecular Discovery Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Molab.ai | Munich, Germany | 2022 |
Cresset Biomolecular Discovery FAQs
-
When was Cresset Biomolecular Discovery founded?
Cresset Biomolecular Discovery was founded in 2002.
-
Where is Cresset Biomolecular Discovery headquartered?
Cresset Biomolecular Discovery is headquartered in Litlington, United Kingdom.
-
What is the size of Cresset Biomolecular Discovery?
Cresset Biomolecular Discovery has 99 total employees.
-
What industry is Cresset Biomolecular Discovery in?
Cresset Biomolecular Discovery’s primary industry is Business/Productivity Software.
-
Is Cresset Biomolecular Discovery a private or public company?
Cresset Biomolecular Discovery is a Private company.
-
What is the current valuation of Cresset Biomolecular Discovery?
The current valuation of Cresset Biomolecular Discovery is .
-
What is Cresset Biomolecular Discovery’s current revenue?
The current revenue for Cresset Biomolecular Discovery is .
-
Who are Cresset Biomolecular Discovery’s investors?
Scottish Equity Partners and Innovate UK have invested in Cresset Biomolecular Discovery.
-
Who are Cresset Biomolecular Discovery’s competitors?
Chemical Computing Group, Conifer Point Pharmaceuticals, Chemify, MathWorks (Business/Productivity Software), and Yoneda Labs are some of the 16 competitors of Cresset Biomolecular Discovery.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
